Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) dropped 0.6% during trading on Tuesday . The company traded as low as $47.21 and last traded at $47.21. Approximately 203 shares traded hands during mid-day trading, a decline of 72% from the average daily volume of 717 shares. The stock had previously closed at $47.50.
Hikma Pharmaceuticals Price Performance
The stock’s 50-day moving average price is $49.99 and its 200-day moving average price is $50.13.
Hikma Pharmaceuticals Cuts Dividend
The firm also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Tuesday, August 20th were paid a dividend of $0.62 per share. This represents a dividend yield of 2.98%. The ex-dividend date was Monday, August 19th. Hikma Pharmaceuticals’s payout ratio is currently 10.34%.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Read More
- Five stocks we like better than Hikma Pharmaceuticals
- Most active stocks: Dollar volume vs share volume
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- The Most Important Warren Buffett Stock for Investors: His Own
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- What is MarketRank™? How to Use it
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
